Shandong Wohua Pharmaceutical Co., Ltd.
Symbole: 002107.SZ
SHZ
4.82
CNYPrix du marché aujourd'hui
64.7237
Ratio P/E
-0.2255
Ratio PEG
2.78B
Cap MRK
- 0.00%
Rendement DIV
Shandong Wohua Pharmaceutical Co., Ltd. (002107-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1553.9 | 401.1 | 278.3 | 326.8 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 489.91 | 120.5 | 165.9 | 120.6 | |||||||||||||||||||||
balance-sheet.row.inventory | 580.07 | 149.1 | 146 | 165.9 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 31.94 | 2.3 | 9 | 7.2 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 2655.83 | 673 | 599.2 | 620.6 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1542.42 | 383.2 | 409.8 | 447.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 130.03 | 32.5 | 32.5 | 32.5 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 144.07 | 36.8 | 36 | 54.8 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 274.1 | 69.4 | 68.5 | 87.3 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 73.91 | 18.4 | 19.1 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 2.8 | 0.7 | 1.2 | 2.8 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 6.43 | 0 | 2.2 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1899.66 | 471.7 | 500.8 | 540.5 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 4555.49 | 1144.7 | 1100 | 1161.1 | |||||||||||||||||||||
balance-sheet.row.account-payables | 223.67 | 52.9 | 45.3 | 26.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 4.7 | 2.7 | 1 | 2.8 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 39.43 | 3.1 | 31.3 | 20.9 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | -17.39 | -17.9 | 0.4 | 0.1 | |||||||||||||||||||||
Deferred Revenue Non Current | 72.77 | 17.9 | 20.7 | 23.8 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17.38 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 762.54 | 226.7 | 224.7 | 168.5 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 75.16 | 5.3 | 26.8 | 28.1 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 1.01 | 0.4 | 0.4 | 0 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1209.2 | 293.3 | 310.2 | 231.8 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 2308.84 | 577.2 | 577.2 | 577.2 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 731.37 | 183.8 | 129.7 | 183.7 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 167.6 | 44.2 | 39.6 | 59.8 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3207.81 | 805.3 | 746.5 | 820.7 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4555.49 | 1144.7 | 1100 | 1161.1 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 120.56 | 28.2 | 43.3 | 108.5 | |||||||||||||||||||||
balance-sheet.row.total-equity | 3328.36 | 833.5 | 789.8 | 929.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4555.49 | - | - | - | |||||||||||||||||||||
Total Investments | 73.91 | 18.4 | 19.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-debt | 4.74 | 2.7 | 1.4 | 2.8 | |||||||||||||||||||||
balance-sheet.row.net-debt | -1549.16 | -398.4 | -276.9 | -324 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 42.99 | 58.8 | 89.9 | 161.3 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | -0.12 | 33.2 | 35.3 | 33 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0.7 | 2.2 | 1.3 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -18.9 | -2.2 | -1.3 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | 44.96 | 47.6 | 54.9 | -14 | |||||||||||||||||||||
cash-flows.row.account-receivables | 50.32 | 50.3 | -40.8 | 63.3 | |||||||||||||||||||||
cash-flows.row.inventory | -5.36 | -5.4 | 15.5 | -53.8 | |||||||||||||||||||||
cash-flows.row.account-payables | 0 | 2.6 | 78.1 | -24.8 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 2.2 | 1.3 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 64.7 | 7.8 | 5.1 | 19.8 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 152.53 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -2.21 | -2.7 | -6.8 | -19.1 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.06 | 0.1 | 1.2 | 0 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 0.06 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -2.15 | -2.6 | -5.6 | -19.1 | |||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.3 | -188.8 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -150.1 | -154.9 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | -3.55 | -3.6 | -79 | -188.8 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.55 | -3.6 | -229.3 | -343.7 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | 147.9 | 122.8 | -49.7 | -162.6 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1551.56 | 401.1 | 276.5 | 326.2 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1403.67 | 278.3 | 326.2 | 488.9 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 152.53 | 129.2 | 185.3 | 200.1 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -2.21 | -2.7 | -6.8 | -19.1 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 150.32 | 126.5 | 178.5 | 181 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 882.86 | 894.3 | 1014.8 | 942.7 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 235.14 | 241.4 | 250.9 | 212.4 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 647.73 | 652.9 | 763.9 | 730.3 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 37.89 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 19.49 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 491.95 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0.2 | -2.3 | 63 | 41.9 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 613.64 | 606.5 | 651.5 | 523.4 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 848.78 | 848 | 902.4 | 735.7 | |||||||||||||||||||||
income-statement-row.row.interest-income | 4.85 | 5.2 | 4.7 | 6.8 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 4.7 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 491.95 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 5.22 | 8.3 | -1.5 | -2.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0.2 | -2.3 | 63 | 41.9 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 5.22 | 8.3 | -1.5 | -2.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.03 | 0 | 0 | 4.7 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 18.56 | 33.2 | 38.5 | 50.1 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 48.25 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 34.94 | 46.3 | 112.3 | 192.7 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 40.17 | 54.6 | 110.8 | 190 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7.01 | 8 | 20.9 | 28.6 | |||||||||||||||||||||
income-statement-row.row.net-income | 42.99 | 58.8 | 107.4 | 163.4 |
Questions fréquemment posées
Quel est le total de Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) de l'actif total?
Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) Le total des actifs est 1144706388.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 401753358.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.734.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.260.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.049.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.040.
Qu'est-ce que Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 58767086.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 2727141.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 606549582.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 456686925.000.